Advanced Search
Search
  
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire

Markets
Stocks
Sectors
Investing Tools
Overview
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
CYBERONICS (NQ: CYBX)
-0.2000 (-1.136%)
at
17.40
28,214 in Volume
Add to:
My Watchlist
Data as of 11:07 AM EST Feb 10,2010
Quote
Overview
Price and Volume
View Detailed Quote
chart
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
Today's Open 17.59
Bid (Size) 17.39 (100)
Ask (Size) 17.40 (100)
Prev. Close 17.60
Today's Range 17.26 - 17.62
52wk Range 12.31 - 21.63
Shares Outstanding 27,754,534
Morningstar Profile
View Full Profile
CYBERONICS
The Company designs, develops, manufactures and markets an implantable medical device that provides vagus nerve stimulation therapy for the treatment of refractory epilepsy and treatment-resistant depression.
Healthcare
Medical Appliances & Equipment
Exchange Traded NQ
Market Cap 482.93M
Related Companies GHDX MWIV FDDSF RAFLF
Featured News
Read More
Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Third Quarter Financial Results
Feb 03, 2010
from PRNewsWire News Releases
Cyberonics' VNS Therapy(TM) System Receives Regulatory Approval in Japan
Jan 19, 2010
from PRNewsWire News Releases
Featured News
Read More
NYU Langone Medical Center Study Shows VNS Therapy is a Safe and Effective Treatment for Refractory Epilepsy
Dec 04, 2009
from PRNewsWire News Releases
Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference
Nov 20, 2009
from PRNewsWire News Releases
Cyberonics Reports Record Sales and Operating Profit in Fiscal 2010 Second Quarter
Nov 18, 2009
from PRNewsWire News Releases
Cyberonics Provides Update on Tax Position
Nov 16, 2009
from PRNewsWire News Releases
More News
Read More
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Conference calls info supplied by OpenCompany
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA